Skip to main content
Erschienen in: Reactions Weekly 1/2011

01.07.2011 | Case report

Etanercept/infliximab

Inflammatory bowel disease, small bowel carcinoma and pancreatic carcinoma: 5 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:
  • death
  • life-threatening
  • hospitalisation
  • disability
  • congenital anomaly
  • requires intervention to prevent permanent impairment or damage
Literatur
1.
Zurück zum Zitat Malipeddi AS, Hassan W.Incidence of Adverse Gastrointestinal Events in Patients on Anti Tnf Therapy. 12th Annual Congress of the European League Against Rheumatism: abstr. AB0410, 25 May 2011. Available from: URL: http://www.eular.org - United Kingdom Malipeddi AS, Hassan W.Incidence of Adverse Gastrointestinal Events in Patients on Anti Tnf Therapy. 12th Annual Congress of the European League Against Rheumatism: abstr. AB0410, 25 May 2011. Available from: URL: http://​www.​eular.​org - United Kingdom
Metadaten
Titel
Etanercept/infliximab
Inflammatory bowel disease, small bowel carcinoma and pancreatic carcinoma: 5 case reports
Publikationsdatum
01.07.2011
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2011
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201113580-00061

Weitere Artikel der Ausgabe 1/2011

Reactions Weekly 1/2011 Zur Ausgabe

Case report

Ondansetron

Case report

Etoricoxib

Case report

Peginterferon-α

Case report

Cefuroxime

Case report

Insulin aspart

Case report

Clozapine